Leveraging Novel T-Cell Engagement Mechanisms to Expand the Therapeutic Window Through Improved Precision, Safety & Immune Modulation
- Developing a differentiated mechanism of action that redirects and amplifies endogenous immune signalling pathways to drive potent T-cell activity while reducing excessive immune activation and treatment-related toxicity
- Demonstrating an improved therapeutic window in non-human primate models through enhanced efficacy, controlled cytokine release, and improved tolerability, supporting the potential for safer clinical application across autoimmune disease settings
- Exploring how precision immune-modulatory approaches can be applied across both oncology and autoimmune indications, leveraging shared mechanistic insights to optimize efficacy, safety management, and long-term therapeutic benefit